HER2 Expression in Urothelial Carcinoma, A Systematic Literature Review

 
 
 
 
 

October’s edition of Frontiers in Oncology features an article co-authored by two Curta researchers, Ashley Kang and Lisa Bloudek. The article summarizes a systematic literature review that identified studies which HER2 experssion is characterized in locally advanced unresectable or metastatic and earlier stage urothelial carcinoma.

To access the full publication, visit:
www.frontiersin.org/articles/10.3389/fonc.2022.1011885/full

 
Previous
Previous

Curta’s Year in Review – 2022

Next
Next

Oncology Simulation Model: A Comprehensive and Innovative Approach to Estimate and Project Prevalence and Survival in Oncology